Protein Information

ID 131
Name C18
Synonyms B1; D1; BBS 9; BBS9; BBS9 GENE; Bardet Biedl syndrome 9 protein; C18; PTH responsive osteosarcoma B1 protein…

Compound Information

ID 106
Name azobenzene
CAS diphenyldiazene

Reference

PubMed Abstract RScore(About this table)
6527240 Fabre H, Hussam-Eddine N, Mandrou B: Stability-indicating assay for phenylbutazone: high-performance liquid chromatographic determination of hydrazobenzene and azobenzene in degraded aqueous phenylbutazone solutions. J Pharm Sci. 1984 Dec;73(12):1706-9.
A high-performance liquid chromatographic method was developed for the simultaneous determination of azobenzene, hydrazobenzene, and four other decomposition products in phenylbutazone injectable formulations. Separation was achieved on a C18 column, with 0.1 M Tris-citrate buffer (pH 5.25) and acetonitrile (52:48), at a flow rate of 2 mL/min and a detection wavelength of 237 nm. Diphenylamine was used as an internal standard. The limit of quantitation is 0.5% (with respect to phenylbutazone) of each degraded product. The detectability is 2.4 X 10 (-3) micrograms for azobenzene and 1.5 X 10 (-3) micrograms for hydrazobenzene. The limit of quantitation may be lowered to 0.1% (with respect to phenylbutazone) for azobenzene and hydrazobenzene in the presence of the two major decomposition products, which have been determined in commercially available injectable formulations. A higher sensitivity was obtained for azobenzene using the mobile phase 0.1 M Tris-citrate buffer (pH = 5.25) and acetonitrile (40:60) with detection at 314 nm. Under these conditions, 0.025% (with respect to phenylbutazone) of azobenzene is quantitated.
1(0,0,0,1)